SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Push who wrote (47)5/13/1999 11:13:00 AM
From: scaram(o)uche  Read Replies (1) of 360
 
At the present time, we are not aware of any intellectual property that would limit
our freedom to commercialize the Flow-thru Chip(TM) probe array.

Geeeze. Biting off a chunk of the work is a biotech tradition here at SI. Could you at least please paste any, in your opinion, relevant portions of the 10-K?

You know us demanding retail investors.

Let me rephrase my question..... you need array molecules on a substrate. What are the broadest claims in issued patents that relate to such deposition, and why do you believe that GLGC is unencumbered?

This isn't a trick question..... I don't have much of a background in this stuff. It's just the first issue that comes to mind for me as I begin an analysis of your company.

Thanks for any help that you can give.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News